Isodiol International Inc. (ISOLF) Stock

About Isodiol International Inc.

Isodiol International Inc. (ISOLF) is a company dedicated to the full spectrum of developing, marketing, distributing, and selling consumer products derived from hemp, alongside related solutions. Its operations span across Canada and the United States. The company focuses on creating and producing specialized consumer phytoceuticals, utilizing pharmaceutical and nutraceutical grade phytochemical compounds. Additionally, Isodiol provides high-purity, pharmaceutical-grade crystalline cannabinoid isolates, which are extracted from non-restricted parts of the hemp plant. It also incorporates advanced delivery systems, such as micro-encapsulation and nanotechnology, into both consumable and topical skincare products. Isodiol's comprehensive product line further includes the manufacturing and distribution of hemp oil and nicotine e-liquids, various personal care items, and distinctive apparel and merchandising solutions. The company also produces and sells hemp-infused beverages and acts as a supplier of pharmaceutical products. Its corporate headquarters are located in Vancouver, Canada.

Isodiol International Inc. (ISOLF) stock trades at $0.00 with a market capitalization of $4914. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Isodiol International Inc. generates a return on equity (ROE) of -215.25%, return on capital employed of -322.11%, an operating margin of -64.61%, a net profit margin of -529.41%.

Official website: isodiol.com